Abstract: Molecular Reproduction and DevelopmentVolume 46, Issue 3 p. 419-439 Review ArticleFree Access H19 in normal development and neoplasia Leendert H.J. Looijenga, Corresponding Author Leendert H.J. Looijenga Laboratory of Experimental Patho-Oncology, Dr. Daniel den Hoed Cancer Center, University Hospital Rotterdam, Rotterdam, the NetherlandsLaboratory of Experimental Patho-Oncology, Dr. Daniel den Hoed Cancer Center, University Hospital Rotterdam, Groene Hilledijk 301, 3075 EA Rotterdam, the NetherlandsSearch for more papers by this authorAnnemieke J.M.H. Verkerk, Annemieke J.M.H. Verkerk Laboratory of Experimental Patho-Oncology, Dr. Daniel den Hoed Cancer Center, University Hospital Rotterdam, Rotterdam, the NetherlandsSearch for more papers by this authorNathan de Groot, Nathan de Groot Department of Biological Chemistry, Institute of Life Sciences, the Hebrew University, Jerusalem, IsraelSearch for more papers by this authorAbraham A. Hochberg, Abraham A. Hochberg Department of Biological Chemistry, Institute of Life Sciences, the Hebrew University, Jerusalem, IsraelSearch for more papers by this authorJ. Wolter Oosterhuis, J. Wolter Oosterhuis Laboratory of Experimental Patho-Oncology, Dr. Daniel den Hoed Cancer Center, University Hospital Rotterdam, Rotterdam, the NetherlandsSearch for more papers by this author Leendert H.J. Looijenga, Corresponding Author Leendert H.J. Looijenga Laboratory of Experimental Patho-Oncology, Dr. Daniel den Hoed Cancer Center, University Hospital Rotterdam, Rotterdam, the NetherlandsLaboratory of Experimental Patho-Oncology, Dr. Daniel den Hoed Cancer Center, University Hospital Rotterdam, Groene Hilledijk 301, 3075 EA Rotterdam, the NetherlandsSearch for more papers by this authorAnnemieke J.M.H. Verkerk, Annemieke J.M.H. Verkerk Laboratory of Experimental Patho-Oncology, Dr. Daniel den Hoed Cancer Center, University Hospital Rotterdam, Rotterdam, the NetherlandsSearch for more papers by this authorNathan de Groot, Nathan de Groot Department of Biological Chemistry, Institute of Life Sciences, the Hebrew University, Jerusalem, IsraelSearch for more papers by this authorAbraham A. Hochberg, Abraham A. Hochberg Department of Biological Chemistry, Institute of Life Sciences, the Hebrew University, Jerusalem, IsraelSearch for more papers by this authorJ. Wolter Oosterhuis, J. Wolter Oosterhuis Laboratory of Experimental Patho-Oncology, Dr. Daniel den Hoed Cancer Center, University Hospital Rotterdam, Rotterdam, the NetherlandsSearch for more papers by this author First published: 07 December 1998 https://doi.org/10.1002/(SICI)1098-2795(199703)46:3<419::AID-MRD22>3.0.CO;2-SCitations: 36AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat References Adam GIR, Cui HM, Miller SJ, Flam F, Ohlsson R (1996): Allele-specific in situ hybridization (ASISH) analysis: A novel technique which resolves differential allelic usage of H19 within the same cell lineage during human placental development. Development 122: 839– 847. Allen ND, Barton SC, Hilton K, Norris ML, Surani MA (1994): A functional analysis of imprinting in parthenogenetic embryonic stem cells. Development 120: 1473– 1482. Andrews PW (1983): The characteristics of cell lines derived from human germ cell tumours. In I Damjanov, BB Knowles, D Solter (eds): " The Biology of Human Teratomas." Clifton: The Human Press, pp. 285– 303. Andrews PW (1984): Pluripotent embryonal carcinoma clones derived from the human teratoma cell line Tera-2: Differentiation in vivo and in vitro. Lab Invest 50: 147– 167. Ariel I, Lustig O, Oyer CE, Elkin M, Gonik B, Rachmilewitz J, Biran H, Goshen R, de Groot N, Hochberg A (1994): Relaxation of imprinting in trophoblastic disease. Gynecol Oncol 53: 212– 219. Ariel I, Lustig O, Schneider T, Pizov G, Sappir M, de Groot N, Hochberg A (1995a): The imprinted H19 gene as a tumor marker in bladder carcinoma. Urology 45: 335– 338. Ariel M, Robinson E, McCarrey JR, Cedar H (1995b): Gamete-specific methylation correlates with imprinting of the murine Xist gene. Nature 9: 312– 315. Arima T (1994): Genetic origin of malignant trophoblastic neoplasms. Cancer Genet Cytogenet 73: 95– 102. Asherson P, Walsh C, Williams J, Sargeant M, Taylor C, Clements A, Gill M, Owen M, McGuffin P (1994): Imprinting and anticipation: Are they relevant to genetic studies of schizophrenia? Brit J Psych 164: 619– 624. Banerjee S, Smallwood A (1995): A chromatin model of IFG2/H19 imprinting. Nature Genet 11: 237– 238. Barlow DP (1993): Methylation and imprinting: From host defence to gene regulation? Science 260: 309– 310. Barlow DP (1994): Imprinting: A gamete's point of view. Trends Genet 10: 194– 199. Barlow DP (1995): Gametic imprinting in mammals. Science 270: 1610– 1613. Barlow DP, Stöger R, Herrmenn BG, Saito K, Schweifer N (1991): The mouse insulin-like growth factor type-2 receptor is imprinted and closely linked to the Tme locus. Nature 349: 84– 87. Bartolomei MS, Zemel S, Tilghman SM (1991): Parental imprinting of the mouse H19 gene. Nature 351: 153– 155. Bartolomei MS, Webber AL, Brunkow ME, Tilghman SM (1993): Epigenetic mechanisms underlying the imprinting of the mouse H19 gene. Genes Dev 7: 1663– 1673. Bender R, Surani MA, Kothary R, Li LL, Fuerst DO, Christ B, Fundele R (1995): Tissue specific loss of proliferative capacity of parthenogenetic cells in fetal mouse chimeras. Roux Arch Developm Biol 204: 436– 443. Bestor TH, Coxon A (1993): Cytosine methylation: The pros and cons of DNA methylation. Curr Biol 3: 384– 386. Biran H, Ariel I, de Groot N, Shani A, Hochberg A (1994): Human imprinted genes as oncodevelopmental markers. Tumor Biol 15: 123– 134. Bird A (1992): The essentials of DNA methylation. Cell 70: 5– 8. Blythe NL, Senior PV, Beck F (1996): Expression of insulin-like growth factor II (IGF-II) and H19 in murine teratocarcinomas derived from embryonic stem (ES) cells. J Anat 188: 65– 74. Boyes J, Bird A (1991): DNA methylation inhibits transcription indirectly via a methyl-CpG binding protein. Cell 64: 1123– 1134. Brandeis M, Kafri T, Ariel M, Chaillet JR, McCarrey J, Razin A, Cedar H (1993): The ontogeney of allele-specific methylation associated with imprinted genes in the mouse. EMBO J 12: 3669– 3677. Brannan CI, Dees EC, Ingram RS, Tighhman SM (1990): The product of the H19 gene may function as an RNA. Molec Cell Biol 10: 28– 36. Bredael J.J, Vugrin D, Whitmore WF Jr. (1982): Autopsy findings in 154 patients with germ cell tumors of the testis. Cancer 50: 548– 551. Brenton JD, Viville S, Surani MA (1995): Genomic imprinting and cancer. Cancer Surv 25: 161– 171. Brown KW, Gardner A, Williams JC, Mott MG, McDermott A, Maitland NJ (1992): Paternal origin of 11p15 duplications in the Beckwith-Wiedemann syndrome: A new case and review of the literature. Cancer Genet Cytogenet 58: 66– 70. Brunkow ME, Tilghman SM (1991): Ectopic expression of the H19 gene in mice causes prenatal lethality. Genes Dev 5: 1092– 1101. Burke AP, Mostofi FK (1993): Spermatocytic seminoma:Aclinicopathologic study of 79 cases. J Urol Pathol 1: 21– 32. Caron H, Van Sluis P, Van Hoeve M, de Kraker J, Bras J, Slater R, Mannens M, Voute PA, Westerveld A, Versteeg R (1993): Allelic loss of chromosome 1p36 in neuroblastoma is of preferential maternal origin and correlates with N-myc amplification. Nat Genet 4: 187– 190. Caron H, Peter M, Van Sluis P, Speleman F, de Kraker J, Laureys G, Michon J, Brugieres L, Voute PA, Westerveld A, Slater R, Delattre O, Versteeg R (1995): Evidence for two tumour suppressor loci on chromosome bands 1p35-36 involved in neuroblastoma: One probably imprinted, another associated with N-myc amplification. Hum Molec Genet 4: 535– 539. Cattanach BM, Burtenshaw MD, Rasberry C, Evans EP (1993): Large deletions and other gross forms of chromosome imbalance compatible with viability and fertility in the mouse. Nature Genet 3: 56– 61. Chaillet JR, Vogt TF, Beier DR, Leder P (1991): Parental-specific methylation of an imprinted transgene is established during gametogenesis and progressively changes during embryogenesis. Cell 66: 77– 83. Chatkupt S, Lucek PR, Koenigsberger MR, Johnson WG (1992): Parental sex effect in spina bifida:A role for genomic imprinting? Am J Med Genet 44: 508– 512. Chatkupt S, Antonowicz M, Johnson WG (1995): Parents do matter: Genomic imprinting and parental sex differences in neurological disorders. J Neurol Sci 130: 1– 10. Chevassu M (1906): " Tumeurs du Testicle." Paris: G. Steinhall. Chung WY, Yuan L, Feng L, Hensle T, Tycko B (1996): Chromosome 11p15.5 regional imprinting: Comparative analysis of KIP2 and H19 in human tissues and Wilms' tumors. Hum Molec Genet 5: 1101– 1108. Clemson CM, McNeil JA, Willard HF, Lawrence JB (1996): XIST RNA paints the inactive X chromosome at interphase: Evidence for a novel RNA involved in nuclear chromosome structure. J Cell Biol 132: 259– 275. Costello CC, Decosse JJ (1992): Possible genomic imprinting in familial adenomatous polyposis [letter]. Lancet 340: 918. Crespi MD, Jurkevitch E, Poiret M, d'Aubenton-Carafa Y, Petrovis G, Kondorosi E, Kondorosi A (1994): enod40, a gene expressed during nodule organogenesis, codes for a non-translatable RNA involved in plant growth. EMBO J 13: 5099– 5112. Cummings OW, Ulbright TM, Eble JN, Roth LM (1994): Spermatocytic seminoma: An immunohistochemical study. Hum Pathol 25: 54– 59. Davies SJ, Hughes HE (1993): Imprinting in Albright's hereditary osteodystrophy. J Med Genet 30: 101– 103. Davis RL, Weintraub H, Lassar AB (1987): Expression of a single transfection cDNA converts fibroblast to myoblast. Cell 51: 987– 1000. De Graaff WE, Oosterhuis JW, De Jong B, Dam A, Van Putten WLJ, Castedo SMMJ, Sleijfer DT, Schraffordt Koops H (1992): Ploidy of testicular carcinoma in situ. Lab Invest 66: 166– 168. De Groot N, Hochberg A (1993): Gene imprinting during placental and embryonic development. Mol Reprod Developm 36: 390– 406. De Groot N, Goshen R, Rachmilewitz J, Gonik B, Ben-Hur H, Hochberg A (1993): Genomic imprinting and β-chorionic gonadotropin. Prenatal Diagn 13: 1159– 1160. De Jong B, Oosterhuis JW, Castedo SMMJ, Vos A, Te Meerman GJ (1990): Pathogenesis of adult testicular germ cell tumors: A cytogenetic model. Cancer Genet Cytogenet 48: 143– 167. Deal CL (1995): Parental genomic imprinting. Curr Opin Pediatr 7: 445– 458. DeChiara TM, Robertson EJ, Efstratiadis A (1991): Parental imprinting of the mouse insuline-like growth factor II gene. Cell 64: 849– 859. Deltour L, Montagutelli X, Guenet JL, Jami J, Paldi A (1995): Tissue and developmental stage–specific imprinting of the mouse proinsulin gene Ins2. Developm Biol 168: 686– 688. Dobrovic A, O'Keefe D, Sage RE, Batchelder E (1993): Imprinting and loss of ABO antigens in leukemia. Blood 82: 1684– 1685. Douc-Rasy S, Coll J, Barrois M, Joubel A, Prost S, Dozier C, Stehelin D, Riou G (1993): Expression of the human fetal BAC/H19 gene in invasive cancers. Int J Oncol 2: 753– 758. Douc-Rasy S, Barrois M, Fogel S, Ahomadegbe JC, Stehelin D, Coll J, Riou G (1996): High incidence of loss of heterozygosity and abnormal imprinting of H19 and IGF2 genes in invasive cervical carcinomas. Uncoupling of H19 and IGF2 expression and biallelic hypomethylaction of H19 Oncogene 12: 423– 430. Dubricella T, Anderson D, Aalberg J, DeWolf WC (1982): Cell surface polarization, tight junctions, and eccentric inner cells characterize human teratocarcinoma embryoid bodies. Developm Biol 94: 197– 205. Dugimont T, Curgy J-J, Wernert N, Delobelle A, Raes M-B, Joubel A, Stehelin D, Coll J (1995): The H19 gene is expressed within both epithelial and stromal components of human invasive adenocarcinomas. Molec Cell 85: 117– 124. Eble JN (1994): Spermatocytic seminoma. Hum Pathol 25: 1035– 1042. Eden S, Cedar H (1994): Role of DNA methylation in the regulation of transcription. Curr Opin Genet Develop 4: 255– 259. Efstratiadis A (1994): Parental imprinting of autosomal mammalian genes. Curr Opin Genet Developm 4: 265– 280. Ekström TJ, Cui H, Li X, Ohlsson R (1995a): Promoter-specific IGF2 imprinting status and its plasticity during human liver development. Development 121: 309– 316. Ekström TJ, Cui H, Nyström A, Rutanen EM, Ohlsson R (1995b): Monoallelic expression of IGF2 at the human fetal/maternal boundary. Molec Reprod Devel 41: 177– 183. Elkin M, Shevelev A, Schulze E, Tyckocinsky M, Cooper M, Ariel I, Pode D, Kopf E, de Groot N, Hochberg A (1995): The expression of the imprinted H19 and IGF-2 genes in human bladder carcinoma. FEBS Letters 374: 57– 61. Eversole-Cire P, Ferguson-Smith AC, Sadaki H, Brown KD, Cattanach BM, Gonzales FA, Surani MA, Jones PA (1993): Activation of an imprinted Igf2 gene in mouse somatic cell cultures. Molec Cell Biol 13: 4928– 4938. Eversole-Cire P, Ferguson-Smith AC, Surani MA, Jones PA (1995): Coordinate regulation of igf-2 and H19 in cultured cells. Cell Growth Diff 6: 337– 345. Ewing J (1911): Teratoma testis and its derivates. Surg Gynecol Obstet 12: 230. Farrer LA, Cupples LA, Connor L, Wolf PA, Growdon JH (1991): Association of decreased paternal age and late-onset Alzheimer's disease:An example of genetic imprinting? Arch Neurol 48: 599– 604. Feil R, Walter J, Allen ND, Reik W (1994): Developmental control of allelic methylation in the imprinted mouse igf2 and H19 genes. Development 120: 2933– 2943. Feinberg AP (1993): Genomic imprinting and gene activation in cancer. Nature Genet 4: 110– 113. Feinberg AP, Rainier S, DeBaun MR (1995): Genomic imprinting, DNA methylation, and cancer. Monogr Natl Cancer Inst 17: 21– 26. Ferguson-Smith AC, Cattanach BM, Barton SC, Beechey CV, Surani MA (1991): Embryological and molecular investigations of parental imprinting on mouse chromosome 7. Nature 351: 667– 670. Ferguson-Smith AC, Sasaki H, Cattanach BM, Surani MA (1993): Parental-origin-specific epigenetic modification of the mouse H19 gene. Nature 362: 751– 754. Fogel M, Lifschitz-Mercer B, Moll R, Kushnir I, Jacob N, Waldherr R, Livoff A, Franke WW, Czernobilsky B (1990): Heterogeneity of intermediate filament expression in human testicular seminomas. Differentiation 45: 242– 249. Franklin GC, Adam GIR, Ohlsson R (1996): Genomic imprinting and mammalian development. Placenta 17: 3– 14. Friedman NB (1951): The comparative morphogenesis of extragenital and gonadal teratoid tumors. Cancer 4: 265– 276. Fundele R, Howlett SK, Kothary R, Norris ML, Mills WE, Surani MA (1991): Developmental potential of parthenogenetic cells: Role of genotype-specific modifiers. Development 113: 941– 946. Fundele RH, Surani MA (1994): Experimental embryological analysis of genetic imprinting in mouse development. Develop Genet 15: 515– 522. Fundele R, Barton SC, Christ B, Krause R, Surani MA (1995a): Distribution of androgenetic cells in fetal mouse chimeras. Roux Arch Developm Biol 204: 484– 493. Fundele R, Li LL, Herzfeld A, Barton SC, Surani MA (1995b): Proliferation and differentiation of androgenetic cells in fetal mouse chimeras. Roux's Arch Developm Biol 204: 494– 501. Furtado S, Suchowersky O (1994): Investigation of the potential role of genetic imprinting in Gilles de la Tourette syndrome. Am J Med Genet 51: 51– 54. Giannoukakis N, Deal C, Paquette J, Kukuvitis A, Polychronakos C (1996): Polymorphic functional imprinting of the human IGF2 gene among individuals, in blood cells, is associated with H19 expression. Biochem Biophys Res Commun 220: 1014– 1019. Giddings SJ, King CD, Harman KW, Flood JF, Carnaghi LR (1994): Allele specific inactivation of insulin 1 and 2, in the mouse yolk sac, indicates imprinting. Nature Genet 6: 310– 313. Glenn CC, Porter KA, Jong MTC, Nicholls RD, Driscoll DJ (1993): Functional imprinting and epigenetic modification of the human SNRPN gene. Hum Molec Genet 2: 2001– 2005. Goshen R, Rachmilewitz J, Schneider T, de Groot N, Ariel I, Palti Z, Hochberg AA (1993): The expression of the H19 and IGF2 genes during human embryogenesis and placental development. Mol Reprod Devel 34: 374– 379. Grigoroiu-Serbanescu M, Nothen M, Propping P, Poustka F (1995): Clinical evidence for genomic imprinting in bipolar I disorder. Acta Psychiatr Scand 92: 365. Guillemot F, Nagy A, Auerbach A, Rossant J, Joyner AL (1994): Essential role of Mash-2 in extraembryonal development. Nature 371: 333– 336. Guillemot F, Caspary T, Tighman SM, Copeland NG, Gilbert DJ, Jenkins NA, Anderson DJ, Joyner AL, Rossant J, Nagy A (1995): Genomic imprinting of Mash2, a mouse gene required for trophoblast development. Nature Genet 9: 235– 241. Haas OA, Argyriou-Tirita A, Lion T (1992): Parental origin of chromosomes involved in the translocation t(9;22). Nature 359: 414– 416. Haig D (1993): Genomic imprinting, human chorionic gonadotropin, and triploidy [letter]. Prenat Diagn 13: 151. Haig D (1994): Is human insulin imprinted? Nature Genetics 7: 10. Hall JG (1990): Genomic imprinting: Review and relevance to human diseases. Am J Hum Genet 46: 857– 873. Han DKM, Liau G (1992): Identification and characterization of developmentally regulated genes in vascular smooth muscle cells. Circ Res 71: 711– 719. Han DKM, Khaing ZZ, Pollock RA, Haudenschild CC, Liau G (1996): H19, a marker of developmental transition, is reexpressed in human atherosclerotic plaques and is regulated by the insulin family of growth factors in cultured rabbit smooth muscle cells. J Clin Invest 97: 1276– 1285. Hao Y, Crenshaw T, Moulton T, Newcomb E, Tycko B (1993): Tumoursuppressor activity of H19 RNA. Nature 365: 764– 767. Hashimoto K, Azuma C, Koyama M, Ohashi K, Kamiura S, Nobunaga T, Kimura T, Tokugawa Y, Kanai T, Saji F (1995): Loss of imprinting in choriocarcinoma. Nature Genet 9: 109– 110. Hatada I, Mukai T (1995): Genomic imprinting of p57kip2, a cyclindependent kinase inhibitor, in mouse. Nat Genet 11: 204– 206. Hatada I, Sugama T, Mukai T (1993): A new imprinted gene cloned by a methylation-sensitive genome scanning method. Nucl Acid Res 21: 5577– 5582. Hatada I, Inazawa J, Abe T, Nakayama M, Kaneko Y, Jinno Y, Niikawa N, Ohashi H, Fukushima Y, Lida K, Yurani C, Takahashi S-i, Chiba Y, Ohishi S, Mukai T (1996): Genomic imprinting of human p57KIP2 and its reduced expression in Wilms' tumors. Hum Molec Genet 5: 783– 788. Hayashizaki Y, Shibata H, Hirotsune S, Sugino H, Okazaki Y, Sasaki N, Hirose K, Imoto H, Okuizumi H, Muramatsu M, Komatsubara H, Shiroishi T, Moriwaki K, Katsuki M, Hatano N, Sasaki H, Ueda T, Mise N, Takagi N, Plass C, Chapman VM (1994): Identification of an imprinted U2af binding protein related sequence on mouse chromosome 11 using the RLGS method. Nature Genet 6: 33– 39. Hergersberg M (1991): Biological aspects of cytosine methylation in eukaryotic cells. Experientia 47: 1171– 1185. Hibi K, Nakamura H, Hirai A, Fujikake Y, Kasai Y, Akiyama S, Ito K, Takagi H (1996): Loss of H19 imprinting in esophageal cancer. Cancer Res 56: 480– 482. Hurst LD, McVean G, Moore T (1996): Imprinted genes have few and small introns. Nature Genet 12: 234– 237. Jinno Y, Yun K, Nishiwaki K, Kubota T, Ogawa O, Reeve AE, Niikawa N (1994): Mosaic and polymorphic imprinting of the WT1 gene in humans. Nature Genet 6: 305– 309. Jinno Y, Ikeda Y, Yun K, Maw M, Masuzaki H, Fukuda T, Inuzuka K, Fujishita A, Ohtani Y, Okimoto T, Ishimaru T, Niikawa N (1995): Establishment of functional imprinting of the H19 gene in human developing placentae. Nature Genet 10: 318– 331. Jinno Y, Sengoku K, Nakao M, Tamate K, Miyamoto T, Matsuzaka T, Sutcliffe JS, Anan T, Takuma N, Nishiwaki K, Ikeda Y, Ishimaru T, Ishikawa M, Niikawa N (1996): Mouse/human sequence divergence in a region with a paternal-specific methylation imprint at the human H19 locus. Hum Molec Genet 5: 1155– 1161. John RM, Surani MA (1996): Imprinted genes and regulation of gene expression by epigenetic inheritance. Curr Opin Cell Biol 8: 348– 353. Johnson DE, Appelt G, Samuels ML, Luna M (1976): Metastases from testicular carcinoma. Urology 8: 234– 239. Junien C (1992): Beckwith-Wiedemann syndrome, tumourigenesis and imprinting. Curr Opin Genet Developm 2: 431– 438. Jørgensen N, Rajpert- De Meyts E, Graem N, Mueller J, Giwercman A, Skakkebaek NE (1995): Expression of immunohistochemical markers for testicular carcinoma in situ by normal human fetal germ cells. Lab Invest 72: 223– 231. Kanbour-Shakir A, Kunz HW, Gill TJ (1993): Differential genomic imprinting of major histocompatibility complex class I antigens in the placenta of the rat. Biol Reprod 48: 977– 986. Kaneko-Isshino T, Kuroiwa Y, Miyoshi N, Kohda T, Suzuki R, Yo-koyama M, Viville S, Barton SC, Ishino F, Surani MA (1995): Peg1/Mest imprinted gene on chromosome 6 identified by cDNA subtraction hybridization. Nat Genet 11: 52– 59. Kay GF, Barton SC, Surani MA, Rastan S (1994): Imprinting and X chromosome counting mechanisms determine Xist expression in early mouse development. Cell 77: 639– 650. Kitsberg D, Selig S, Brandeis M, Simon I, Keshet I, Driscoll DJ, Nicholls RD, Cedar H (1993): Allele-specific replication timing of imprinted gene regions. Nature 364: 459– 463. Koi M, Johnson LA, Kalikin LM, Little PFR, Nakamura Y, Feinberg AP (1993): Tumor cell growth arrest caused by subchromosomal transfectable DNA fragments form chromosome 11. Science 260: 361– 364. Kondo M, Suzuki H, Ueda R, Osada H, Takagi K, Takahashi T (1995): Frequent loss of imprinting of the H19 gene is often associated with its overexpression in human lung cancers. Oncogene 10: 1193– 1198. Kondo M, Matsuoka S, Uchida K, Osada H, Nagatake M, Takagi K, Harper JW, Takahashi T, Elledge SJ (1996): Selective maternal-allele loss in human lung cancers of the maternally expressed p57KIP2 gene at 11p15.5. Oncogene 12: 1365– 1368. Kuroiwa Y, Kaneko-Ishino T, Kahitani F, Kohda T, Li LL, Tada M, Suzuki R, Ykoyama M, Shiroishi T, Wakana S, Barton SC, Ishino F, Surani MA (1996): Peg3 imprinted gene on proximal chromosome 7 encodes for a zinc finger protein. Nature Genet 12: 186– 190. LaBuda MC, Fletcher NA, Korczyn AD, Inzelberg R, Harding AE, Pauls DL (1993): Genomic imprinting and anticipation in idiopathic torsion dystonia. Neurology 43: 2040– 2043. Laird CD (1991): The X-inactivation imprinting model of the fragile-X syndrome: Annotated references, 1990. Prog Clin Biol Res 368: 101– 110. Langlois S (1994): Genomic imprinting: a new mechanism for disease. Pediatr Pathol 14: 161– 165. Latham KE (1995): Stage-specific and cell type–specific aspects of genomic imprinting effects in mammals. Development 269– 282. Latham KE, Solter D (1991): Effect of egg composition on the developmental capacity of androgenetic mouse embryos. Development 113: 561– 568. Latham KE, McGrath J, Solter D (1995): Mechanistic and developmental aspects of genetic imprinting in mammals. Int Rev Cytol 160: 53– 98. Leff SE, Brannan CI, Reed ML, Ozcelik T, Francke U, Copeland NG, Jenkins NA (1993): Maternal imprinting of the mouse Snrpn gene and conserved linkage homology with the human Prader-Willi syndrome region. Nature Genet 2: 259– 264. Leighton PA, Ingram RS, Eggenschwiler J, Efstratiadis A, Tilghman SM (1995a): Disruption of imprinting caused by deletion of the H19 gene region in mice. Nature 375: 34– 39. Leighton PA, Saam JR, Ingram RS, Stewart CL, Tilghman SM (1995b): An enhancer deletion affects both H19 and Igf2 expression. Genes Developm 9: 2079– 2089. Leighton PA, Saam JR, Ingram RS, Tilghman SM (1996): Genomic imprinting in mice: its function and mechanism. Biol Reproduc 54: 273– 278. Li E, Bestor TH, Jaenisch R (1992): Targeted mutation of the DNA methyltransferase gene results in embryonic lethality. Cell 69: 915– 926. Li E, Beard C, Jaenisch R (1993): Role of DNA methylation in genomic imprinting. Nature 366: 362– 365. Li XR, Adam G, Cui HM, Sandstedt B, Ohlsson R, Ekstrom TJ (1995): Expression, promoter usage and parental imprinting status of insulin-like growth factor II (IGF2) in human hepatoblastoma: Uncoupling of IGF2 and H19 imprinting. Oncogene 11: 221– 229. Lichter DG, Jackson LA, Schachter M (1995): Clinical evidence of genomic imprinting in Tourette's syndrome. Neurology 45: 924– 928. Lindor NM, Ney JA, Gaffey TA, Jenkins RB, Thibodeau SN, Dewald GW (1992): A genetic review of complete and partial hydatidiform moles and nonmolar triploidy. Mayo Clin Proc 67: 791– 799. Looijenga LH, Oosterhuis JW, Ramaekers FC, De Jong B, Dam A, Beck JL, Sleijfer DT, Schraffordt Koops H (1991): Dual parameter flow cytometry for deoxyribonucleic acid and intermediate filament proteins of residual mature teratoma: All tumor cells are aneuploid. Lab Invest 64: 113– 117. Looijenga LHJ, Abraham M, Gillis AJM, Saunders GF, Oosterhuis JW (1994): Testicular germ cell tumors of adults show deletions of chromosomal bands 11p13 and 11p15.5, but no abnormalities within the zinc-finger regions and exons 2 and 6 of the Wilms tumor 1 gene. Genes Chromosom Cancer 9: 153– 160. Lorberboum-Galski H, Yarkoni S, Nechushtan A, Rachmilewitz J, De Groot N, Hochberg A (1994): ABL and BCR genes are not imprinted in androgenetic and gynogenetic human tissues. Biochem Biophys Res Commun 204: 621– 627. Lothe RA, Fossä SD, Stenwig AE, Nakamura Y, White R, Børresen AL, Brøgger A (1989): Loss of 3p or 11p alleles is associated with testicular cancer tumors. Genomics 5: 134– 138. Lothe RA, Hastie N, Heimdal K, Fossä SD, Stenwig AE, Børresen AL (1993): Frequent loss of 11p13 and 11p15 loci in male germ cell tumours. Genes Chromos Cancer 7: 96– 101. Lothe RA, Peltomaeki P, Tommerup N, Fossä SD, Stenwig AE, Børresen AL, Nesland JM (1995): Molecular genetic changes in human male germ cell tumors. Lab Invest 73: 606– 614. Lustig O, Ariel I, Ilan J, Lev-Lehman E, De Groot N, Hochberg A (1994): Expression of the imprinted gene H19 in the human fetus. Molec Reprod Develop 38: 239– 246. Manivel JC, Niehans G, Wick MR, Dehner LP (1987): Intermediate trophoblast in germ cell neoplasms. Am J Surg Pathol 11 (9): 693– 701. Mann JR, Stewart CL (1991): Development to term of mouse androgenetic aggregation chimeras. Development 113: 1325– 1333. Mann JR, Gadi I, Harbison ML, Abbondanzo SJ, Stewart CL (1990): Androgenetic mouse embryonic stem cells are pluripotent and cause skeletal defects in chimeras: Implications for genetic imprinting. Cell 62: 251– 260. Mannens M, Slater RM, Heyting C, Bliek J, de Kraker J, Coad N, de Pagter-Holthuizen P, Pearson PL (1988): Molecular nature of genetic changes resulting in loss of heyterozygosity of chromosome 11 in Wilms tumours. Hum Genet 81: 41– 48. Mannens M, Devilee P, Bliek J, Mandjes I, de Kraker J, Heyting C, Slater RM, Westerveld A (1990): Loss of heterozygosity in Wilms tumors, studied for six putative tumor supressor regions, is limited to chromosome 11. Cancer Res 50: 3279– 3283. Mannens M, Hoovers JMN, Redeker E, Verjaal M, Feinberg AP, Little P, Boavida M, Coad N, Steenman M, Bliek J, Niikawa N, Tonoki H, Nakamura Y, De Boer EG, Slater RM, John R, Cowell JK, Junien C, Henry I